“We think investors are less excited about the rest of the pipeline,” the analyst ... and JPMorgan were among those to reiterate their buy-equivalent ratings on Regeneron (NASDAQ:REGN) despite ...

Fintel reports that on May 30, 2025, Wells Fargo downgraded their outlook for Regeneron Pharmaceuticals (NasdaqGS:REGN) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 68.40% Upside ...

The S&P 500 slipped less than 0.1% on Friday, May 30, 2025, as President Trump rekindled his tough rhetoric on China and a ...

Fintel reports that on February 5, 2025, Leerink Partners upgraded their outlook for Regeneron Pharmaceuticals ... What are Other Shareholders Doing? Jpmorgan Chase holds 7,490K shares ...

Ulta Beauty ( ULTA) was the best-performing stock in the S&P 500 after the beauty products retailer beat profit and sales ...

Fintel reports that on May 30, 2025, Wells Fargo downgraded their outlook for Regeneron Pharmaceuticals (BMV:REGN) from Overweight to Equal-Weight. Jpmorgan Chase holds 5,658K shares representing ...

Fintel reports that on May 30, 2025, Wells Fargo downgraded their outlook for Regeneron Pharmaceuticals ... 113,247K shares. Jpmorgan Chase holds 5,658K shares representing 5.45% ownership ...

All three major averages closed out May with sizable gains Friday, with the S&P 500 and Nasdaq Composite seeing their best month since November 2023.